
Elanco Animal Health Incorporated
ELAN
#1694
Rank
$12.526 B
Marketcap
United States
Country
$25.08
Share price
10.34%
Change (1 day)
18.44%
Change (1 year)
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, anβ¦
Key Metrics
Trailing P/E
β
Forward P/E
17.43
EPS (TTM)
$-0.41
Forward EPS
$1.29
Price / Book
1.70
EV / EBITDA
14.8x
Beta
1.68
Dividend Yield
β
Return on Equity
-2.98%
Return on Assets
1.56%
Debt / Equity
64.25
Current Ratio
2.05
Gross Margin
55.36%
Operating Margin
8.63%
Net Profit Margin
-3.96%
Free Cash Flow
$826.875M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 β Sep 18
-8.49%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual Β· USD
RevenueNet Income
Latest Revenue$4.715B
Latest Net Income$-232,000,000
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Elanco Animal Health Incorporated with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
ELAN
No recent news available. Set FINNHUB_API_KEY to enable news.







